Core Viewpoint - The company plans to use its own funds to pay for part of the fundraising project expenses and subsequently replace these with equivalent amounts from the raised funds, which is deemed to enhance operational efficiency and ensure the smooth progress of the fundraising projects [1][6][7]. Fundraising Overview - The company has received approval from the China Securities Regulatory Commission to issue 30.8 million A-shares at a price of RMB 31.33 per share, raising a total of RMB 964.96 million. After deducting issuance costs of RMB 86.84 million, the net amount raised is RMB 878.12 million [1]. - As of June 30, 2025, the company has utilized RMB 441.25 million of the raised funds, with RMB 107.00 million directly invested in fundraising projects [4]. Fundraising Project Details - The company has postponed the completion date for several fundraising projects from January 25, 2025, to January 25, 2027, and added its wholly-owned subsidiary, Sichuan Junyi Su Lian Technology Co., Ltd., as a co-implementing entity for these projects [2][3]. - The total investment for the underground comprehensive pipeline smart management operation platform upgrade project and the new smart city comprehensive solution enhancement project is RMB 321.04 million [2]. Reasons for Using Own Funds - The company needs to pay for labor costs, including salaries and social insurance, which cannot be directly paid from the fundraising account as per regulations. Therefore, it plans to use its own funds initially and later replace them with raised funds [5][6]. Operational Process for Fund Replacement - The company will follow a specific payment process where the finance department will pay the relevant project expenses using its own funds and subsequently transfer equivalent amounts from the fundraising account to its own account within six months [6][7]. Impact on the Company - The decision to use its own funds for project expenses is expected to improve operational management efficiency and ensure the smooth implementation of fundraising projects, complying with relevant regulations [6][7]. Review and Opinions - The board of directors and the supervisory board have approved the plan, confirming that it follows necessary procedures and does not affect the normal execution of fundraising projects or harm shareholder interests [7][9]. - The sponsor, Huayin Securities, has also expressed no objections to the plan, affirming its compliance with regulations [9].

证券代码：688163 证券简称：赛伦生物 公告编号：2025-021 上海赛伦生物技术股份有限公司 关于使用自有资金支付募投项目人员费用 并以募集资金等额置换的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 上海赛伦生物技术股份有限公司（以下简称"公司"）于 2025 年 8 月 25 日 召开第四届董事会第八次会议，审议通过了《关于使用自有资金支付募投项目人 员费用并以募集资金等额置换的议案》，同意公司在募投项目实施期间，根据实 际需要，先行使用自有资金支付募投项目人员费用，后续定期从募集资金专户划 转等额资金至公司自有资金账户进行置换，该部分等额置换资金视同募投项目使 用资金，上述事项无需提交公司股东会审议。保荐机构方正证券承销保荐有限责 任公司对本事项出具了明确的核查意见。现将具体情况公告如下： 一、募集资金基本情况 根据中国证券监督管理委员会《关于同意上海赛伦生物技术股份有限公司首 次公开发行股票注册的批复》（证监许可【2022】204 号）的批准，公司获准向 社会公开发行人民币普通股 2,706 万股，每 ...

西南证券股份有限公司 关于广东松发陶瓷股份有限公司使用募集资金置换 预先投入募投项目的自筹资金的核查意见 西南证券股份有限公司（以下简称"西南证券"或"独立财务顾问"）作为 广东松发陶瓷股份有限公司（以下简称"松发股份"、"上市公司"或"公司"） 的独立财务顾问，根据《上市公司募集资金监管规则》《上海证券交易所上市公 司自律监管指引第 1 号——规范运作》等相关法律法规和规范性文件的规定，对 松发股份使用募集资金置换预先投入募投项目的自筹资金的事项进行了审慎核 查，具体情况如下： 一、募集资金基本情况 根据中国证券监督管理委员会《关于同意广东松发陶瓷股份有限公司发行股 份购买资产并募集配套资金注册的批复》（证监许可〔2025〕1032 号），公司向 特定对象发行人民币普通股（A 股）109,080,992 股，发行价格为人民币 36.67 元 /股，募集资金总额为人民币 3,999,999,976.64 元，扣除各项发行费用人民币 通合伙）审验并出具了中汇会验[2025]10382 号《验资报告》。 为规范公司募集资金的管理和使用，保护投资者的权益，根据中国证监会《上 市公司募集资金监管规则》《上海证券交易所 ...

Group 1 - The board meeting was held on August 20, 2025, with all 7 directors present, and the meeting complied with relevant laws and regulations [1][2] - The board approved the use of raised funds to replace self-raised funds used for project investments and issuance expenses, totaling 264,100 RMB (excluding VAT) [1][2] - The board agreed to use up to 330 million RMB of idle raised funds for cash management, focusing on low-risk, high-liquidity financial products with a maximum investment period of 12 months [2][3] Group 2 - The board approved the temporary use of up to 100 million RMB of idle raised funds to supplement working capital, limited to operations related to the main business, with a maximum usage period of 12 months [3][4] - The board agreed to use self-owned funds and bank acceptance bills to pay for project expenses, with plans to replace these with raised funds later [4][5] - The board unanimously agreed to hold the second temporary shareholders' meeting on September 8, 2025 [5]

Group 1 - The core point of the news is the approval of several proposals by the Supervisory Board of Ningbo Yokogawa Precision Industrial Co., Ltd. regarding the use of raised funds and cash management [1][2][3][4][5] Group 2 - The Supervisory Board meeting was held on August 20, 2025, with all three supervisors present, and the meeting complied with relevant laws and regulations [1] - The proposal to replace self-raised funds with raised funds for pre-invested projects and paid issuance expenses was approved, amounting to 264,100 yuan (excluding VAT) [1][2] - The proposal to use up to 330 million yuan of idle raised funds for cash management in safe and liquid products was approved, with a maximum investment period of 12 months [2][3] - The proposal to temporarily supplement working capital with up to 100 million yuan of idle raised funds was approved, limited to a maximum period of 12 months [3][4] - The proposal to use self-owned funds and bank acceptance bills for project payments, later to be replaced with raised funds, was approved, ensuring compliance with regulations and no impact on project progress [4][5]

Core Viewpoint - The company intends to use its own funds and bank acceptance bills to pay for fundraising project expenses, subsequently replacing these with raised funds in an equivalent amount, which is deemed to enhance operational efficiency and ensure the smooth progress of fundraising projects [2][6][7] Fundraising Basic Information - The company issued 45,300,462 A-shares at a price of 12.98 yuan per share, raising a total of approximately 588 million yuan, with a net amount of about 583 million yuan after deducting issuance costs [2][3] Fundraising Investment Project Details - The total investment for the fundraising projects is approximately 593.56 million yuan, with about 588 million yuan planned to be invested from the raised funds [3] Reasons for Using Own Funds and Acceptance Bills - The company opted to use its own funds and bank acceptance bills for initial payments due to regulatory restrictions on salary payments from the fundraising account and the need for operational efficiency in handling taxes and other expenses [4][5] Operational Process for Fund Replacement - The company has established a detailed process for replacing its own funds with raised funds, including monthly statistics and necessary approvals to ensure compliance and proper documentation [5] Impact on Company Operations - The use of own funds and acceptance bills is expected to improve operational efficiency, enhance fund turnover, and not affect the implementation of fundraising projects or shareholder interests [5][6] Review Procedures and Opinions - Both the board of directors and the supervisory board have approved the use of own funds and acceptance bills, confirming that the process adheres to necessary regulations and does not alter the intended use of raised funds [6][7]

Core Viewpoint - The company, Ningbo Henghe Precision Industry Co., Ltd., is utilizing raised funds to replace pre-invested self-raised funds for investment projects and paid issuance expenses, in compliance with relevant regulations [2][8]. Fundraising Basic Information - The company issued 45,300,462 A-shares at a price of 12.98 RMB per share, raising a total of approximately 588 million RMB, with a net amount of about 583 million RMB after deducting issuance expenses [2][3]. Investment Project Information - The total investment for the projects funded by the raised capital is approximately 593.56 million RMB, with 588 million RMB planned to be allocated from the raised funds [3][4]. Pre-Investment and Replacement Details - The company pre-invested approximately 123.37 million RMB from self-raised funds before the raised funds were in place, which includes 123.11 million RMB for investment projects and 264,074.39 RMB for issuance expenses [4][5]. Approval Procedures and Opinions - The board of directors and the supervisory board have approved the use of raised funds to replace pre-invested self-raised funds, confirming compliance with relevant regulations and ensuring no impact on the normal progress of investment projects [7][8][9].

Core Viewpoint - The company is utilizing its own funds to pay for investment projects and will subsequently replace these funds with raised capital, ensuring efficient use of funds and smooth project implementation [1][6][7] Fundraising Overview - The company issued 16,229,100 shares at a par value of 1.00 RMB per share, raising a total of approximately 1.31 billion RMB after deducting issuance costs [1][2] - The total expected investment for the projects funded by the raised capital is approximately 434.36 million RMB [2][3] Investment Project Details - The company has established a dedicated account for the raised funds, which are fully stored in this account and are subject to a tripartite/four-party supervision agreement with the sponsor and the bank [2] - The net amount raised from the initial public offering is 1,308,998,865.06 RMB, with excess funds available for investment [3] Reasons for Using Own Funds - The company’s U.S. subsidiary, Bepharm Scientific Inc, initially paid for automation equipment costing 1.5 million USD due to delays in foreign investment filing [4][5] - Payments for salaries, bonuses, and other operational costs must be made from the company's basic deposit account, not from the raised funds account, to comply with banking regulations [4] - Frequent small payments for project-related expenses would complicate fund management if made directly from the raised funds account, thus necessitating the use of own funds initially [5] Operational Process for Fund Replacement - The company will submit payment requests for project-related expenses, initially using its own funds, and will replace these with raised funds within six months following the payment [6] - A detailed record will be maintained to ensure compliance with the investment project requirements [6] Impact on Daily Operations - The use of own funds followed by replacement with raised funds is expected to enhance the efficiency of fund utilization and project implementation without affecting the normal operation of investment projects [6][7] Review Procedures - The board of directors has approved the use of own funds for project expenses, ensuring compliance with relevant regulations and confirming that this does not alter the intended use of raised funds [6][7]

Core Viewpoint - The company has announced the use of its own funds to pay for part of the fundraising investment projects, which will later be replaced with equivalent amounts from the raised funds, ensuring the smooth implementation of the projects [1][5][6] Fundraising Basic Information - The company raised a total of 680 million RMB through a non-public offering of A-shares, with the funds deposited in designated bank accounts [1][2] - The total amount of funds raised after deducting issuance costs is 680 million RMB, with additional amounts for taxes and fees [1] Investment Project Details - The initial investment projects included the "New Media Commercial Big Data Platform Construction Project" and the "WEIQ New Media Marketing Cloud Platform Upgrade Project," with a total investment of 251.51 million RMB and intended fundraising of 207.19 million RMB [2] - The projects were later changed to "Content Marketing Ecosystem Platform Upgrade Project" and "Innovative Technology Module Upgrade Project," with a revised total investment of 131.96 million RMB and intended fundraising of 126.24 million RMB [2][3] Reasons for Using Own Funds - The company needs to use its own funds for salary payments and other operational costs to comply with banking regulations, as using raised funds directly for these purposes is impractical [3][4] - This approach aims to enhance the efficiency of fund usage and ensure the smooth progress of the investment projects [3][5] Operational Process for Fund Replacement - The company will transfer the equivalent amount from the raised funds to its own accounts within six months after using its own funds for project payments [4][5] Approval and Opinions - The board and supervisory committee have approved the use of own funds for project payments, confirming that this does not alter the intended use of raised funds or harm shareholder interests [5][6] - The sponsor has also expressed no objections to the company's plan, affirming compliance with relevant regulations [5]

Meeting Details - The first session of the Supervisory Board's twelfth meeting was held on August 18, 2025, via communication, with all three supervisors present [2] - The meeting was chaired by Shao Fusheng and complied with relevant regulations [2] Resolutions Passed - The Supervisory Board approved the proposal to use raised funds to replace self-raised funds previously invested in fundraising projects, which enhances the efficiency of fund usage and aligns with shareholder interests [3][12] - The amount approved for replacement is RMB 235,252.84 million [3][12] Fundraising Overview - The company fully exercised the over-allotment option on August 14, 2025, raising a total of RMB 2,370,185,970.00, with a net amount of RMB 2,352,528,432.93 after deducting issuance costs [7][10] - The initial public offering (IPO) raised a total of RMB 15,801,242,600.52 before the over-allotment option, with a net amount of RMB 15,591,873,069.05 after costs [9] Pre-Investment and Replacement Arrangement - The company utilized self-raised funds for preliminary investments in fundraising projects before the raised funds were received, with the replacement amount being RMB 235,252.84 million [11] - The replacement arrangement was approved in the meetings held on August 18, 2025, and complies with legal requirements [8][11] Opinions from Relevant Parties - The Supervisory Board confirmed that the replacement of self-raised funds with raised funds does not alter the intended use of the funds and protects shareholder interests [12][14] - Ernst & Young Huaming issued a report affirming that the pre-investment report complies with relevant regulations [13] - The sponsor institution verified that the necessary procedures were followed and agreed with the fund replacement proposal [14]